Isawa T, Teshima T, Hirano T, Ebina A, Konno K
Tohoku J Exp Med. 1986 Sep;150(1):51-61. doi: 10.1620/tjem.150.51.
The purpose of the study was to investigate whether or not orally administered salbutamol would affect mucociliary clearance function in the lungs. Salbutamol, 4 mg, was given orally 3 times a day for 7 days to 10 and 9 patients with various chest diseases in stable stage, respectively; the former were also currently taking other medications and the latter, none. Lung function tests, chest x-rays and radioaerosol inhalation lung cine-scintigraphy were performed before and after the administration of salbutamol. There was little qualitative or quantitative difference in mucociliary clearance function in either group before and after the administration of oral salbutamol, although it induced some increases in VC and FEV1.0 and a decrease in RV/TLC ratio in the former and some increases in FEV1.0, FEV1.0% and MMF in the latter. Oral salbutamol seems little to affect the mucociliary clearance function in the lungs.
该研究的目的是调查口服沙丁胺醇是否会影响肺部的黏液纤毛清除功能。分别对10例和9例处于稳定期的各种胸部疾病患者口服4毫克沙丁胺醇,每日3次,共7天;前者同时还服用其他药物,后者未服用其他药物。在给予沙丁胺醇前后进行肺功能测试、胸部X光检查和放射性气溶胶吸入肺闪烁造影。口服沙丁胺醇后,两组的黏液纤毛清除功能在定性或定量方面几乎没有差异,尽管它使前者的肺活量(VC)和第1秒用力呼气容积(FEV1.0)有所增加,残气量/肺总量(RV/TLC)比值降低,使后者的FEV1.0、FEV1.0%和最大呼气中期流速(MMF)有所增加。口服沙丁胺醇似乎对肺部的黏液纤毛清除功能影响很小。